melatonin has been researched along with Carcinoma in 18 studies
Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plasma melatonin was determined in samples of patients with colorectal carcinoma and in controls using an iodinated radioimmunoassay." | 7.67 | Plasma melatonin levels in patients suffering from colorectal carcinoma. ( Khoory, R; Stemme, D, 1988) |
| "Melatonin (MLT) is an indolic hormone produced mainly by the pineal gland." | 5.39 | Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism. ( Liu, H; Song, J; Wang, RX; Xu, L; Zhang, H; Zhou, RX, 2013) |
| "Ovarian cancer is the fourth most common cause of cancer deaths among women, and chronic alcoholism may exert co-carcinogenic effects." | 5.39 | Characterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatment. ( Chuffa, LG; Fávaro, WJ; Fioruci-Fontanelli, BA; Martinez, FE; Martinez, M; Mendes, LO; Pinheiro, PF, 2013) |
| "The synergetic use of Somatostatin, Melatonin, Retinoids, Vitamins C, D3, and E, Calcium, sulphated Aminoglucosides, and minimum doses of cyclophosphamide in a 70-year old male patient with inoperable scarcely differentiated oesophageal carcinoma, has provided, from the beginning of treatment in 1995 to the present date, an excellent quality of life, as well as a cure with functional recovery." | 3.75 | Complete objective response of oesophageal squamocellular carcinoma to biological treatment. ( Di Bella, G; Madarena, M, 2009) |
| "The purpose of this study was to assess DNA damage of tumor-associated lymphocytes (TALs) in malignant pleural effusion (MPE), the total antioxidant capacity (TAC) of plasma and MPE from patients with carcinoma, and DNA repair effect of melatonin." | 3.72 | DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients. ( Liu, X; Zhao, J; Zheng, R, 2003) |
| "Plasma melatonin was determined in samples of patients with colorectal carcinoma and in controls using an iodinated radioimmunoassay." | 3.67 | Plasma melatonin levels in patients suffering from colorectal carcinoma. ( Khoory, R; Stemme, D, 1988) |
| "Melatonin was given orally at 20 mg/day in the evening for at least 2 months." | 2.70 | Anti-angiogenic activity of melatonin in advanced cancer patients. ( Bucovec, R; Conti, A; Lissoni, P; Maestroni, GJ; Malugani, F; Rovelli, F, 2001) |
| "Melatonin (MLT) is a molecule secreted by the pineal gland in cyclical periods." | 2.47 | Melatonin and cancer: current knowledge and its application to oral cavity tumours. ( Aneiros-Cachaza, J; Aneiros-Fernández, J; Arias-Santiago, S; Cutando, A, 2011) |
| "Of particular relevance to breast cancer risk, melatonin may also block the estrogen receptor ERalpha and impact the enzyme aromatase, which produces estradiol." | 2.45 | Circulating melatonin and the risk of breast and endometrial cancer in women. ( Schernhammer, ES; Viswanathan, AN, 2009) |
| "Melatonin (MLT) is an indolic hormone produced mainly by the pineal gland." | 1.39 | Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism. ( Liu, H; Song, J; Wang, RX; Xu, L; Zhang, H; Zhou, RX, 2013) |
| "Ovarian cancer is the fourth most common cause of cancer deaths among women, and chronic alcoholism may exert co-carcinogenic effects." | 1.39 | Characterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatment. ( Chuffa, LG; Fávaro, WJ; Fioruci-Fontanelli, BA; Martinez, FE; Martinez, M; Mendes, LO; Pinheiro, PF, 2013) |
| "Isoproterenol (10(-6) M) was applied for 20 min after 2." | 1.32 | Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis. ( De Jonage-Canonico, MB; Kerdelhué, B; Lenoir, V; Martin, A; Scholler, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baxter, B | 1 |
| Xu, L | 1 |
| Liu, H | 1 |
| Zhang, H | 1 |
| Wang, RX | 1 |
| Song, J | 1 |
| Zhou, RX | 1 |
| Chuffa, LG | 1 |
| Fioruci-Fontanelli, BA | 1 |
| Mendes, LO | 1 |
| Fávaro, WJ | 1 |
| Pinheiro, PF | 1 |
| Martinez, M | 1 |
| Martinez, FE | 1 |
| Ho, HY | 1 |
| Lin, CW | 1 |
| Chien, MH | 1 |
| Reiter, RJ | 1 |
| Su, SC | 1 |
| Hsieh, YH | 1 |
| Yang, SF | 1 |
| Viswanathan, AN | 1 |
| Schernhammer, ES | 1 |
| Di Bella, G | 1 |
| Madarena, M | 1 |
| Cutando, A | 1 |
| Aneiros-Fernández, J | 1 |
| Aneiros-Cachaza, J | 1 |
| Arias-Santiago, S | 1 |
| Kisková, T | 1 |
| Ekmekcioglu, C | 2 |
| Garajová, M | 1 |
| Orendáš, P | 1 |
| Bojková, B | 1 |
| Bobrov, N | 1 |
| Jäger, W | 2 |
| Kassayová, M | 1 |
| Thalhammer, T | 2 |
| De Jonage-Canonico, MB | 1 |
| Lenoir, V | 1 |
| Martin, A | 1 |
| Scholler, R | 1 |
| Kerdelhué, B | 1 |
| Liu, X | 1 |
| Zhao, J | 1 |
| Zheng, R | 1 |
| Aust, S | 1 |
| Humpeler, S | 1 |
| Klimpfinger, M | 1 |
| Tucek, G | 1 |
| Obrist, P | 1 |
| Marktl, W | 1 |
| Penner, E | 1 |
| Lewiński, A | 1 |
| Sewerynek, E | 1 |
| Wajs, E | 1 |
| Lopaczyński, W | 1 |
| Sporny, S | 1 |
| Lissoni, P | 2 |
| Rovelli, F | 1 |
| Malugani, F | 1 |
| Bucovec, R | 1 |
| Conti, A | 2 |
| Maestroni, GJ | 1 |
| Lapin, V | 1 |
| Barni, S | 1 |
| Cazzaniga, M | 1 |
| Ardizzoia, A | 1 |
| Paolorossi, F | 1 |
| Brivio, F | 1 |
| Perego, M | 1 |
| Tancini, G | 1 |
| Maestroni, G | 1 |
| Sheĭnina, LI | 1 |
| Kutivadze, DA | 1 |
| Sulava, TA | 1 |
| Gabuniia, UA | 1 |
| Kvetnoĭ, IM | 1 |
| Khoory, R | 1 |
| Stemme, D | 1 |
| Hamilton, T | 1 |
3 reviews available for melatonin and Carcinoma
| Article | Year |
|---|---|
Circulating melatonin and the risk of breast and endometrial cancer in women.
Topics: Aromatase; Breast Neoplasms; Carcinoma; Case-Control Studies; Cell Transformation, Neoplastic; Circa | 2009 |
Melatonin and cancer: current knowledge and its application to oral cavity tumours.
Topics: Antioxidants; Carcinoma; Humans; Melatonin; Mouth Neoplasms; Receptors, Melatonin | 2011 |
Pineal gland and malignancy.
Topics: Age Factors; Animals; Breast Neoplasms; Carcinogens; Carcinoma; Female; Gonadotropins; Humans; Lymph | 1976 |
1 trial available for melatonin and Carcinoma
| Article | Year |
|---|---|
Anti-angiogenic activity of melatonin in advanced cancer patients.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; C | 2001 |
14 other studies available for melatonin and Carcinoma
| Article | Year |
|---|---|
Is melatonin of value in cancer treatment? Experience with a case of feline mammary carcinoma.
Topics: Animals; Carcinoma; Cat Diseases; Cats; Female; Mammary Neoplasms, Animal; Melatonin; Treatment Outc | 2017 |
Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Carcinoma; Cell Line, Tumor; Cell Proliferation; | 2013 |
Characterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatment.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma; Estrous Cycle; Ethanol; Female; Melatonin; Ova | 2013 |
Melatonin suppresses TPA-induced metastasis by downregulating matrix metalloproteinase-9 expression through JNK/SP-1 signaling in nasopharyngeal carcinoma.
Topics: Carcinoma; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expressi | 2016 |
Complete objective response of oesophageal squamocellular carcinoma to biological treatment.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; | 2009 |
A combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
Topics: Algorithms; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Carcinoma; Chemopr | 2012 |
Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenergic beta-Agonists; Animals; Antioxidants; Carcinogens; Carc | 2003 |
DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients.
Topics: Antioxidants; Carcinoma; Comet Assay; DNA Damage; DNA Repair; Humans; Lymphocytes, Tumor-Infiltratin | 2003 |
The melatonin receptor subtype MT1 is expressed in human gallbladder epithelia.
Topics: Acetylserotonin O-Methyltransferase; Arylalkylamine N-Acetyltransferase; Arylamine N-Acetyltransfera | 2004 |
Effects of the pineal gland on the growth processes of Guerin epithelioma in male Wistar rats.
Topics: Animals; Carcinoma; Life Expectancy; Male; Melatonin; Mitosis; Neoplasm Invasiveness; Neoplasms, Exp | 1993 |
Neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinoma.
Topics: Adult; Aged; Biopterins; Carcinoma; Colorectal Neoplasms; Combined Modality Therapy; Eosinophils; Fe | 1992 |
[Functional morphology of breast APUD cells in dysplasia and neoplastic processes].
Topics: Adenofibroma; Adrenocorticotropic Hormone; APUD Cells; beta-Endorphin; Breast Neoplasms; Carcinoma; | 1989 |
Plasma melatonin levels in patients suffering from colorectal carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoembryonic Antigen; Carcinoma; Circadian Rhythm; Colonic Neoplasms; H | 1988 |
Influence of environmental light and melatonin upon mammary tumour induction.
Topics: Adenocarcinoma; Adenofibroma; Animals; Benz(a)Anthracenes; Carcinoma; Female; Light; Mammary Neoplas | 1969 |